212 related articles for article (PubMed ID: 22273986)
1. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
[TBL] [Abstract][Full Text] [Related]
2. [Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany].
Schurr R; Stölzel U; Schuppan D; Schwertner C; Steinberg J; Scherübl H
Dtsch Med Wochenschr; 2006 Jul; 131(30):1649-55. PubMed ID: 16850381
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns.
Verhoef C; Visser O; de Man RA; de Wilt JH; IJzermans JN; Janssen-Heijnen ML
Eur J Cancer; 2004 Jul; 40(10):1530-8. PubMed ID: 15196537
[TBL] [Abstract][Full Text] [Related]
4. Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.
Kaczynski J; Hansson G; Wallerstedt S
Hepatogastroenterology; 2005; 52(66):1798-802. PubMed ID: 16334780
[TBL] [Abstract][Full Text] [Related]
5. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence.
Moore SW; Millar AJ; Hadley GP; Ionescu G; Kruger M; Poole J; Stones D; Wainwright L; Chitnis M; Wessels G
Cancer; 2004 Aug; 101(3):642-9. PubMed ID: 15274079
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
8. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
9. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma.
Sapisochin G; Fidelman N; Roberts JP; Yao FY
Liver Transpl; 2011 Aug; 17(8):934-42. PubMed ID: 21438129
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival.
Witjes CD; Karim-Kos HE; Visser O; de Vries E; IJzermans JN; de Man RA; Coebergh JW; Verhoef C
HPB (Oxford); 2012 Nov; 14(11):777-81. PubMed ID: 23043667
[TBL] [Abstract][Full Text] [Related]
11. Temporal and biological trends in liver cancers at a University hospital in Southwest Nigeria.
Otegbayo JA; Oluwasola OA; Akere A; Ogunbiyi JO
Trop Doct; 2006 Jan; 36(1):28-30. PubMed ID: 16483427
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis.
Pocobelli G; Cook LS; Brant R; Lee SS
Liver Int; 2008 Nov; 28(9):1272-9. PubMed ID: 18384523
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
14. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology of primary and secondary liver cancers].
Jepsen P; Kissmeyer-Nielsen P
Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
[TBL] [Abstract][Full Text] [Related]
18. Kentucky hepatoma: epidemiologic variant or same problem in a different region?
Martin RC; Loehle J; Scoggins CR; McMasters KM
Arch Surg; 2007 May; 142(5):431-6; discussion 436-7. PubMed ID: 17515484
[TBL] [Abstract][Full Text] [Related]
19. Time trends in the incidence of hepatocellular carcinoma in liver cirrhosis. A retrospective necropsy study in a large Romanian town (1973-1992).
Acalovschi M; Pascu M; Iobagiu S; Ban A; Olinici DC; Petrescu M
Rom J Intern Med; 1996; 34(1-2):85-90. PubMed ID: 8908635
[TBL] [Abstract][Full Text] [Related]
20. Time and deprivation trends in incidence of primary liver cancer subtypes in England.
Konfortion J; Coupland VH; Kocher HM; Allum W; Grocock MJ; Jack RH
J Eval Clin Pract; 2014 Aug; 20(4):498-504. PubMed ID: 24902884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]